[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f2y_cvrLwtSWse6N5xHtoiQkQ30-VuP_SQcMFO6gWkoU":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":9,"nonDrugCount":11,"topConditions":12,"upcomingReadouts":33,"phaseBuckets":39,"rows":46},"LMU Klinikum",[4],51,false,18,1,42808,45,[13,16,19,22,24,26,29,31],{"name":14,"count":15},"Tricuspid Regurgitation",5,{"name":17,"count":18},"Inclusion Body Myositis",4,{"name":20,"count":21},"Heart Failure",3,{"name":23,"count":21},"Coronary Artery Disease",{"name":25,"count":21},"Mitral Regurgitation",{"name":27,"count":28},"Pacemaker Complication",2,{"name":30,"count":28},"Acute Coronary Syndrome",{"name":32,"count":28},"Atrial Fibrillation",[34],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT06315972","Combining Clemastine and Aerobic Exercise to Treat Cognitive Dysfunction in Schizophrenia by Targeting Myelin Plasticity","2026-11","clemastine",[40,41,42,43,44,45],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[47,71,110,132,160,178,196,214,245,263,281],{"intervention":38,"totalTrials":9,"cells":48},{"EARLY_PHASE1":49,"PHASE1":52,"PHASE2":54,"PHASE3":65,"PHASE4":67,"NA":69},{"trials":50,"activeCount":51},[],0,{"trials":53,"activeCount":51},[],{"trials":55,"activeCount":9,"soonestReadout":37},[56],{"nctId":35,"briefTitle":36,"status":57,"phases":58,"primaryCompletion":37,"completion":59,"start":60,"enrollment":61,"conditions":62,"interventions":64},"NOT_YET_RECRUITING",[42],"2028-04","2024-04",90,[63],"Schizophrenia",[38],{"trials":66,"activeCount":51},[],{"trials":68,"activeCount":51},[],{"trials":70,"activeCount":51},[],{"intervention":72,"totalTrials":28,"cells":73},"Prasugrel",{"EARLY_PHASE1":74,"PHASE1":76,"PHASE2":78,"PHASE3":80,"PHASE4":82,"NA":108},{"trials":75,"activeCount":51},[],{"trials":77,"activeCount":51},[],{"trials":79,"activeCount":51},[],{"trials":81,"activeCount":51},[],{"trials":83,"activeCount":51},[84,97],{"nctId":85,"briefTitle":86,"status":87,"phases":88,"primaryCompletion":89,"completion":90,"start":91,"enrollment":92,"conditions":93,"interventions":95},"NCT02548611","Comparison of Loading Strategies With Antiplatelet Drugs in Patients Undergoing Elective Coronary Intervention","TERMINATED",[44],"2018-08","2018-11","2015-09",795,[94],"Angina Pectoris",[72,96],"Clopidogrel",{"nctId":98,"briefTitle":99,"status":100,"phases":101,"primaryCompletion":102,"completion":103,"start":104,"enrollment":105,"conditions":106,"interventions":107},"NCT01959451","Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment For Acute Coronary Syndromes Trial","COMPLETED",[44],"2016-05","2017-06","2013-09",2600,[30],[72,96],{"trials":109,"activeCount":51},[],{"intervention":96,"totalTrials":28,"cells":111},{"EARLY_PHASE1":112,"PHASE1":114,"PHASE2":116,"PHASE3":118,"PHASE4":120,"NA":130},{"trials":113,"activeCount":51},[],{"trials":115,"activeCount":51},[],{"trials":117,"activeCount":51},[],{"trials":119,"activeCount":51},[],{"trials":121,"activeCount":51},[122,126],{"nctId":85,"briefTitle":86,"status":87,"phases":123,"primaryCompletion":89,"completion":90,"start":91,"enrollment":92,"conditions":124,"interventions":125},[44],[94],[72,96],{"nctId":98,"briefTitle":99,"status":100,"phases":127,"primaryCompletion":102,"completion":103,"start":104,"enrollment":105,"conditions":128,"interventions":129},[44],[30],[72,96],{"trials":131,"activeCount":51},[],{"intervention":133,"totalTrials":9,"cells":134},"Mycophenolate Mofetil",{"EARLY_PHASE1":135,"PHASE1":137,"PHASE2":139,"PHASE3":141,"PHASE4":156,"NA":158},{"trials":136,"activeCount":51},[],{"trials":138,"activeCount":51},[],{"trials":140,"activeCount":51},[],{"trials":142,"activeCount":51},[143],{"nctId":144,"briefTitle":145,"status":87,"phases":146,"primaryCompletion":147,"completion":147,"start":148,"enrollment":149,"conditions":150,"interventions":152},"NCT05570409","Immunosuppressive Treatment in Chronic Virus-Negative Inflammatory Cardiomyopathy",[42,43],"2025-04-14","2023-03-28",9,[151],"Inflammatory Cardiomyopathy",[133,153,154,155],"Prednisolone","Mycophenolate Mofetil Placebo","Prednisolone Placebo",{"trials":157,"activeCount":51},[],{"trials":159,"activeCount":51},[],{"intervention":153,"totalTrials":9,"cells":161},{"EARLY_PHASE1":162,"PHASE1":164,"PHASE2":166,"PHASE3":168,"PHASE4":174,"NA":176},{"trials":163,"activeCount":51},[],{"trials":165,"activeCount":51},[],{"trials":167,"activeCount":51},[],{"trials":169,"activeCount":51},[170],{"nctId":144,"briefTitle":145,"status":87,"phases":171,"primaryCompletion":147,"completion":147,"start":148,"enrollment":149,"conditions":172,"interventions":173},[42,43],[151],[133,153,154,155],{"trials":175,"activeCount":51},[],{"trials":177,"activeCount":51},[],{"intervention":154,"totalTrials":9,"cells":179},{"EARLY_PHASE1":180,"PHASE1":182,"PHASE2":184,"PHASE3":186,"PHASE4":192,"NA":194},{"trials":181,"activeCount":51},[],{"trials":183,"activeCount":51},[],{"trials":185,"activeCount":51},[],{"trials":187,"activeCount":51},[188],{"nctId":144,"briefTitle":145,"status":87,"phases":189,"primaryCompletion":147,"completion":147,"start":148,"enrollment":149,"conditions":190,"interventions":191},[42,43],[151],[133,153,154,155],{"trials":193,"activeCount":51},[],{"trials":195,"activeCount":51},[],{"intervention":155,"totalTrials":9,"cells":197},{"EARLY_PHASE1":198,"PHASE1":200,"PHASE2":202,"PHASE3":204,"PHASE4":210,"NA":212},{"trials":199,"activeCount":51},[],{"trials":201,"activeCount":51},[],{"trials":203,"activeCount":51},[],{"trials":205,"activeCount":51},[206],{"nctId":144,"briefTitle":145,"status":87,"phases":207,"primaryCompletion":147,"completion":147,"start":148,"enrollment":149,"conditions":208,"interventions":209},[42,43],[151],[133,153,154,155],{"trials":211,"activeCount":51},[],{"trials":213,"activeCount":51},[],{"intervention":215,"totalTrials":9,"cells":216},"Genetic test: ACE polymorphism",{"EARLY_PHASE1":217,"PHASE1":219,"PHASE2":221,"PHASE3":223,"PHASE4":225,"NA":227},{"trials":218,"activeCount":51},[],{"trials":220,"activeCount":51},[],{"trials":222,"activeCount":51},[],{"trials":224,"activeCount":51},[],{"trials":226,"activeCount":51},[],{"trials":228,"activeCount":51},[229],{"nctId":230,"briefTitle":231,"status":232,"phases":233,"primaryCompletion":234,"completion":235,"start":236,"enrollment":237,"conditions":238,"interventions":242},"NCT05272969","Pompe & Pain - Study to Assess Nociceptive Pain in Adult Patients With Pompe Disease","UNKNOWN",[],"2024-05-30","2024-09-03","2022-03-31",95,[239,17,240,241],"Pompe Disease (Late-onset)","Spinal Muscular Atrophy Type 3","FSHD",[215,243,244],"Genetic test: ACTN3 polymorphism","Blood draw for optional genetic exome sequencing",{"intervention":243,"totalTrials":9,"cells":246},{"EARLY_PHASE1":247,"PHASE1":249,"PHASE2":251,"PHASE3":253,"PHASE4":255,"NA":257},{"trials":248,"activeCount":51},[],{"trials":250,"activeCount":51},[],{"trials":252,"activeCount":51},[],{"trials":254,"activeCount":51},[],{"trials":256,"activeCount":51},[],{"trials":258,"activeCount":51},[259],{"nctId":230,"briefTitle":231,"status":232,"phases":260,"primaryCompletion":234,"completion":235,"start":236,"enrollment":237,"conditions":261,"interventions":262},[],[239,17,240,241],[215,243,244],{"intervention":244,"totalTrials":9,"cells":264},{"EARLY_PHASE1":265,"PHASE1":267,"PHASE2":269,"PHASE3":271,"PHASE4":273,"NA":275},{"trials":266,"activeCount":51},[],{"trials":268,"activeCount":51},[],{"trials":270,"activeCount":51},[],{"trials":272,"activeCount":51},[],{"trials":274,"activeCount":51},[],{"trials":276,"activeCount":51},[277],{"nctId":230,"briefTitle":231,"status":232,"phases":278,"primaryCompletion":234,"completion":235,"start":236,"enrollment":237,"conditions":279,"interventions":280},[],[239,17,240,241],[215,243,244],{"intervention":282,"totalTrials":9,"cells":283},"glucosidase alfa",{"EARLY_PHASE1":284,"PHASE1":286,"PHASE2":288,"PHASE3":290,"PHASE4":292,"NA":294},{"trials":285,"activeCount":51},[],{"trials":287,"activeCount":51},[],{"trials":289,"activeCount":51},[],{"trials":291,"activeCount":51},[],{"trials":293,"activeCount":51},[],{"trials":295,"activeCount":51},[296],{"nctId":297,"briefTitle":298,"status":100,"phases":299,"primaryCompletion":300,"completion":301,"start":302,"enrollment":303,"conditions":304,"interventions":306},"NCT02824068","Long-term Outcome in Late-onset Pompe Disease Treated Beyond 36 Months (STIG-Pompe-Study)",[],"2019-12-31","2020-12-31","2016-06-01",112,[305],"Pompe Disease",[282]]